Synopsis
Synopsis
0
USDMF
0
EU WC
0
KDMF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4,5-dihydro-6-(2-(4-methoxyphenyl)-1h-benzimidazole-5-yl)-5-methyl-3(2h)-pyridazinone
2. Pimobendane
3. Ud Cg 115
4. Ud-cg 115
5. Ud-cg115
1. 74150-27-9
2. Pimobendane
3. Acardi
4. Dl-pimobendan
5. Vetmedin
6. D-pimobendan
7. (-)-pimobendan
8. Pimobendan, (-)-
9. (+)-pimobendan
10. Pimobendanum
11. Ud-cg 115 Bs
12. Ud-cg 115
13. 118428-37-8
14. Pimobendan, (+)-
15. Pimobendan (vetmedin)
16. Ud-cg-115bs
17. Racemic Pimobendan
18. 118428-38-9
19. Udcg-115
20. 6-(2-(4-methoxyphenyl)-1h-benzo[d]imidazol-5-yl)-5-methyl-4,5-dihydropyridazin-3(2h)-one
21. Ud-cg-115
22. 3-[2-(4-methoxyphenyl)-3h-benzimidazol-5-yl]-4-methyl-4,5-dihydro-1h-pyridazin-6-one
23. Brn 4207330
24. 34ap3bbp9t
25. Chembl24646
26. 613jxv89su
27. 9htu209z0n
28. Chebi:32003
29. 3(2h)-pyridazinone, 4,5-dihydro-6-(2-(4-methoxyphenyl)-1h-benzimidazol-5-yl)-5-methyl-, (+)-
30. 3(2h)-pyridazinone, 4,5-dihydro-6-(2-(4-methoxyphenyl)-1h-benzimidazol-5-yl)-5-methyl-, (-)-
31. L-pimobendan
32. Racemic Pinobendan
33. 6-(2-(4-methoxyphenyl)-1h-benzo[d]imidazol-6-yl)-5-methyl-4,5-dihydropyridazin-3(2h)-one
34. 6-[2-(4-methoxyphenyl)-1h-benzimidazol-5-yl]-5-methyl-4,5-dihydropyridazin-3(2h)-one
35. Pimobendan [inn-spanish]
36. Pimobendane [inn-french]
37. Pimobendanum [inn-latin]
38. (+)-ud-cg 115bs
39. (-)-ud-cg 115bs
40. Ncgc00274063-01
41. Unii-34ap3bbp9t
42. Unii-613jxv89su
43. Unii-9htu209z0n
44. Pimobendan [usan:inn:ban]
45. Ud-cg115
46. 3-[2-(4-methoxyphenyl)-1h-benzimidazol-5-yl]-4-methyl-4,5-dihydro-1h-pyridazin-6-one
47. Acardi (tn)
48. Pimobendan - Vetmedin
49. Pimobendan [mi]
50. Pimobendan [inn]
51. Pimobendan [jan]
52. Pimobendan [usan]
53. Pimobendan [mart.]
54. (+)-4,5-dihydro-6-(2-(4-methoxyphenyl)-1h-benzimidazol-5-yl)-5-methyl-3(2h)-pyridazinone
55. (-)-4,5-dihydro-6-(2-(4-methoxyphenyl)-1h-benzimidazol-5-yl)-5-methyl-3(2h)-pyridazinone
56. 4,5-dihydro-6-[2-(4-methoxyphenyl)-1h-benzimidazol-5-yl]-5-methyl-3(2h)-pyridazinone
57. 6-(2-(4-methoxyphenyl)-4,5-dihydro-1h-benzimidazol-5-yl)-5-methyl-3(2h)-pyridazinone
58. Pimobendan [usp-rs]
59. Pimobendan [who-dd]
60. Schembl27623
61. Mls006010188
62. Pimobendan (jan/usan/inn)
63. Pimobendan [green Book]
64. Dtxsid8048280
65. Pimobendan [ep Impurity]
66. Pimobendan, >=98% (hplc)
67. Hms3655i03
68. Hms3884c21
69. Kuc109647n
70. Pimobendan [usp Monograph]
71. Bcp02958
72. Hy-b0204
73. Ac-689
74. Bdbm50282617
75. Mfcd00761648
76. S1550
77. Akos015851937
78. Akos015967705
79. Ccg-267853
80. Db11450
81. Ks-1280
82. 3(2h)-pyridazinone, 4,5-dihydro-6-(2-(4-methoxyphenyl)-1h-benzimidazol-5-yl)-5-methyl-
83. 6-[2-(4-methoxy-phenyl)-1h-benzoimidazol-5-yl]-5-methyl-4,5-dihydro-2h-pyridazin-3-one
84. Ksc-210-009
85. Pimobendan [ema Epar Veterinary]
86. Fortekor Plus Component Pimobendan
87. Ncgc00274063-04
88. Ncgc00274063-05
89. 118428-36-7
90. Pimobendan 100 Microg/ml In Acetonitrile
91. Smr002530068
92. Bcp0726000255
93. Ft-0630830
94. P2779
95. Pimobendan Component Of Fortekor Plus
96. Sw219717-1
97. D01133
98. Ab01274800-01
99. Ab01274800_02
100. 150p279
101. Q414351
102. J-517984
103. Pimobendan, United States Pharmacopeia (usp) Reference Standard
104. 4,5-dihydro-6-[2-(4-methoxy-phenyl)-1h-benzimidazol-5-yl]-5-methyl-3 (2h)-pyridazinone
105. Pimobendan For System Suitability, European Pharmacopoeia (ep) Reference Standard
106. (+/-)-4,5-dihydro-6-(2-(p-methoxyphenyl)-5-benzimidazolyl)-5-methyl-3(2h)-pyridazinone
107. 3(2h)-pyridazinone, 4,5-dihydro-6-(2-(4-methoxyphenyl)-1h-benzimidazol-5-yl)-5-methyl-, (+/-)-
108. 3(2h)-pyridazinone, 4,5-dihydro-6-(2-(4-methoxyphenyl)-1h-benzimidazol-6-yl)-5-methyl-
Molecular Weight | 334.4 g/mol |
---|---|
Molecular Formula | C19H18N4O2 |
XLogP3 | 2.7 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 3 |
Exact Mass | 334.14297583 g/mol |
Monoisotopic Mass | 334.14297583 g/mol |
Topological Polar Surface Area | 79.4 Ų |
Heavy Atom Count | 25 |
Formal Charge | 0 |
Complexity | 530 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
Phosphodiesterase Inhibitors
Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases. (See all compounds classified as Phosphodiesterase Inhibitors.)
Cardiotonic Agents
Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
40
PharmaCompass offers a list of Pimobendan API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Pimobendan manufacturer or Pimobendan supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pimobendan manufacturer or Pimobendan supplier.
PharmaCompass also assists you with knowing the Pimobendan API Price utilized in the formulation of products. Pimobendan API Price is not always fixed or binding as the Pimobendan Price is obtained through a variety of data sources. The Pimobendan Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Pimobendan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pimobendan, including repackagers and relabelers. The FDA regulates Pimobendan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pimobendan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Pimobendan manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Pimobendan supplier is an individual or a company that provides Pimobendan active pharmaceutical ingredient (API) or Pimobendan finished formulations upon request. The Pimobendan suppliers may include Pimobendan API manufacturers, exporters, distributors and traders.
click here to find a list of Pimobendan suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Pimobendan Drug Master File in Japan (Pimobendan JDMF) empowers Pimobendan API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Pimobendan JDMF during the approval evaluation for pharmaceutical products. At the time of Pimobendan JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Pimobendan suppliers with JDMF on PharmaCompass.
A Pimobendan CEP of the European Pharmacopoeia monograph is often referred to as a Pimobendan Certificate of Suitability (COS). The purpose of a Pimobendan CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Pimobendan EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Pimobendan to their clients by showing that a Pimobendan CEP has been issued for it. The manufacturer submits a Pimobendan CEP (COS) as part of the market authorization procedure, and it takes on the role of a Pimobendan CEP holder for the record. Additionally, the data presented in the Pimobendan CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Pimobendan DMF.
A Pimobendan CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Pimobendan CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Pimobendan suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Pimobendan as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Pimobendan API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Pimobendan as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Pimobendan and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Pimobendan NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Pimobendan suppliers with NDC on PharmaCompass.
Pimobendan Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pimobendan GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pimobendan GMP manufacturer or Pimobendan GMP API supplier for your needs.
A Pimobendan CoA (Certificate of Analysis) is a formal document that attests to Pimobendan's compliance with Pimobendan specifications and serves as a tool for batch-level quality control.
Pimobendan CoA mostly includes findings from lab analyses of a specific batch. For each Pimobendan CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pimobendan may be tested according to a variety of international standards, such as European Pharmacopoeia (Pimobendan EP), Pimobendan JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pimobendan USP).